This is not the trial(s) with Remestemcel. This is for trials focused on treating fistulas, using other sources of MSCs.
These trials on fistulas had primary completion dates in October and November 2022. The trials with Remestemcel, which focus on the overall conditions of Chrohn’s and Ulcerative Colitis have primary completion dates of November of 2023. It was nice to get a sneak peak last year, but we may not hear more until the trials are complete.
DREAM HF Trial Video, page-87
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |